ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 160 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,849,000 | +71.0% | 450,000 | -10.0% | 1.20% | +45.4% |
| Q1 2019 | $12,190,000 | +47.3% | 500,000 | -13.9% | 0.82% | +22.6% |
| Q4 2018 | $8,276,000 | -9.3% | 580,756 | -3.2% | 0.67% | +13.3% |
| Q3 2018 | $9,120,000 | -18.7% | 600,000 | -10.3% | 0.59% | -28.6% |
| Q2 2018 | $11,222,000 | +2.8% | 668,743 | 0.0% | 0.83% | +2.0% |
| Q1 2018 | $10,914,000 | +21.8% | 668,743 | -4.5% | 0.81% | -13.2% |
| Q4 2017 | $8,960,000 | -19.1% | 700,000 | -22.2% | 0.94% | -52.0% |
| Q3 2017 | $11,070,000 | +47.0% | 900,000 | 0.0% | 1.96% | +56.5% |
| Q2 2017 | $7,533,000 | -6.4% | 900,000 | 0.0% | 1.25% | +6.9% |
| Q1 2017 | $8,046,000 | -20.4% | 900,000 | -21.7% | 1.17% | -14.3% |
| Q4 2016 | $10,109,000 | +30.2% | 1,150,000 | 0.0% | 1.36% | +59.2% |
| Q3 2016 | $7,763,000 | +100.3% | 1,150,000 | +35.3% | 0.86% | +38.3% |
| Q3 2015 | $3,876,000 | -36.8% | 850,000 | 0.0% | 0.62% | -24.0% |
| Q2 2015 | $6,129,000 | -2.2% | 850,000 | 0.0% | 0.82% | -15.8% |
| Q1 2015 | $6,265,000 | +32.5% | 850,000 | -15.0% | 0.97% | +32.8% |
| Q4 2014 | $4,730,000 | +32.5% | 1,000,000 | 0.0% | 0.73% | -0.7% |
| Q3 2014 | $3,570,000 | -21.7% | 1,000,000 | 0.0% | 0.73% | -39.2% |
| Q2 2014 | $4,560,000 | -44.6% | 1,000,000 | -42.9% | 1.21% | -36.1% |
| Q1 2014 | $8,225,000 | -6.2% | 1,750,000 | 0.0% | 1.89% | -25.7% |
| Q4 2013 | $8,768,000 | – | 1,750,000 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |